2023
DOI: 10.1007/s00296-023-05310-9
|View full text |Cite
|
Sign up to set email alerts
|

Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey

Abstract: The safety profile of COVID-19 vaccines is understudied in patients with systemic sclerosis (SSc). We compared shortterm adverse events (AEs) 7 days following vaccination in patients with SSc vs other rheumatic (AIRDs), non-rheumatic autoimmune diseases (nrAIDs), and healthy controls (HCs). The COVID-19 Vaccination in autoimmune diseases (COVAD) self-reporting e-survey was circulated by a group of > 110 collaborators in 94 countries from March to December 2021. AEs were analyzed between different groups using … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…The effects of anti-COVID-19 vaccination are reported in small patients' series [ [31] , [32] , [33] , [34] , [35] , [36] ], showing a generally good tolerability to different anti-COVID-19 vaccines, mostly mRNA types [ [19] , [20] , [21] , 35 , 37 ]. The percentage of impaired seroconversion largely varied among different patients’ series [ 19 , 31 , 34 , 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…The effects of anti-COVID-19 vaccination are reported in small patients' series [ [31] , [32] , [33] , [34] , [35] , [36] ], showing a generally good tolerability to different anti-COVID-19 vaccines, mostly mRNA types [ [19] , [20] , [21] , 35 , 37 ]. The percentage of impaired seroconversion largely varied among different patients’ series [ 19 , 31 , 34 , 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%